Med Holdings Group Inc. (OTC: YUKA) Announces Strategic Negotiations With Leading Urology Authority Dr. Harvey Samowitz as Company Accelerates Expansion, Digital Scale, and Corporate Milestones
MWN-AI** Summary
Med Holdings Group Inc. (OTC: YUKA) has announced a strategic partnership with Dr. Harvey Samowitz, a prominent authority in urology and sexual wellness, to enhance its clinical leadership and accelerate expansion efforts. Dr. Samowitz, who brings over 30 years of expertise in urology and female pelvic medicine, is expected to strengthen the company's position within high-demand markets while fostering a robust national brand.
Jessica Miller, CEO of Med Holdings, emphasized the significance of aligning with elite medical professionals, setting a clear roadmap to scale operations, achieve compliance milestones, and ultimately enhance shareholder value. In tandem with Dr. Samowitz's potential involvement, Med Holdings is actively exploring expansions into key demographic areas in Jupiter and Doral, Florida, which are projected to bolster recurrent revenue streams and enhance brand presence regionally.
Additionally, the company is fast-tracking its audit process and working on changes including a name and ticker symbol revision via FINRA, aimed at improving corporate transparency and market appeal. A significant milestone was the launch of TotallBody.com, a digital platform designed to expand Med Holdings' reach beyond physical locations, tapping into a vast, underserved U.S. healthcare market and allowing scalable service engagement.
Over the past year, YUKA shares have surged over 500%, reflecting increased investor interest and confidence in the company's strategic vision. With committed expansion capital, a clear multi-location rollout strategy, and a scalable digital infrastructure, Med Holdings Group appears to be well-positioned for continued growth into 2026 and beyond. The company has expressed gratitude to its stakeholders and promises ongoing updates as expansion initiatives develop.
MWN-AI** Analysis
Med Holdings Group Inc. (OTC: YUKA) is showing strong potential for growth following its recent announcement regarding strategic negotiations with Dr. Harvey Samowitz, a leading authority in urology. With Dr. Samowitz's extensive experience and qualifications, this partnership is poised to enhance the company’s clinical credibility and expand its service offerings in the high-demand urology and sexual wellness markets.
The company’s focus on entering affluent regions, such as Jupiter and Doral, Florida, is strategic, enabling targeted marketing and potentially high recurring revenues. The rationale behind these specific markets aligns with demographic insights, indicating a commitment to establishing brand dominance in lucrative areas. With recent stock appreciation exceeding 500% and a current market capitalization over $3 million, investor sentiment appears to reflect optimism regarding Med Holdings’ trajectory.
Furthermore, the company's digital launch of TotallBody.com is a significant milestone, as it represents a shift toward a scalable healthcare platform that can access a wider audience, alleviating some of the constraints of traditional brick-and-mortar business models. By enhancing its online presence, Med Holdings not only expands its market reach but also taps into the growing trend of telehealth and digital engagement, which is crucial as patient preferences evolve.
However, potential investors should remain cautious and consider the risks associated with OTC stocks. Factors such as management transitions, the execution of growth strategies, and regulatory hurdles could impact performance. As the company moves through its audit fast-tracking and FINRA name change, which aim to enhance transparency and visibility, investors should stay informed about these developments.
In summary, Med Holdings Group Inc. is strategically positioned for future growth, especially with its robust expansion plans and digital strategy. Investors looking for opportunities in the healthcare sector may find YUKA worthy of consideration while remaining mindful of the inherent risks.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
DENVER, COLORADO - February 18, 2026 (NEWMEDIAWIRE) - Med Holdings Group Inc. (OTC: YUKA) today announced it has entered into advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a move that would significantly strengthen the Company’s clinical leadership as it rapidly expands its footprint and national platform.
Dr. Samowitz brings more than 30 years of experience in urology, sexual medicine, and pelvic health. Board certified by the American Board of Urology and subspecialty certified in Female Pelvic Medicine and Reconstructive Surgery, he is widely respected for his clinical expertise, published research, and leadership within the urological community.
He maintains affiliations with:
- American Urological Association (AUA), Southeastern Section
- American College of Surgeons
- Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU)
- American Society for Men’s Health (Founding Member)
- American Mensa Society
- Greater Miami Urological Society
- Phi Delta Epsilon Medical Fraternity, Beta Tau Chapter
This is a defining moment for Med Holdings Group,” stated Jessica Miller, Chief Executive Officer of Med Holdings Group Inc. “Our strategy is simple: align with elite medical leadership, scale into high-demand markets, accelerate compliance milestones, and build a nationally recognized brand. Dr. Samowitz’s potential involvement reflects the caliber of professionals we are bringing into our ecosystem as we position the Company for sustained growth and shareholder value creation.”
Along with the following, she added:
Active Expansion into High-Growth Markets
Med Holdings Group is currently in active negotiations for two additional locations:
• Jupiter, Florida
• Doral, Florida
These markets align directly with the Company’s demographic strategy and high-income target base. Management anticipates these additions will materially strengthen recurring revenue and regional brand dominance.
Audit Fast-Track & FINRA Name/Ticker Change
The Company is accelerating completion of its audit process while actively advancing its FINRA name change and ticker symbol change. These steps are intended to enhance transparency, strengthen corporate alignment, and increase market visibility as the Company scales operations.
National Digital Launch: TotallBody.com
Med Holdings Group has officially launched its enhanced national platform, TotallBody.com, significantly expanding its addressable market beyond brick-and-mortar locations.
The platform provides:
- Immediate national brand exposure
- Access to a large, underserved U.S. market
- Scalable digital engagement for services and future vertical expansion
Management views this as a foundational step toward building a nationally scalable healthcare platform.
Market Momentum
Over the past twelve months, YUKA has appreciated more than 500%, with the Company’s market capitalization now exceeding $3 million. Management believes this growth reflects increasing investor awareness and recognition of the Company’s strategic direction and execution.
Positioned for 2026 and Beyond
With:
- Committed expansion capital
- A clear acquisition and multi-location rollout strategy
- Accelerating compliance and corporate milestones
- Expanding clinical leadership
- A scalable national digital infrastructure
Med Holdings Group Inc. believes it is strategically positioned for continued operational and market growth into 2026 and beyond.
The Company appreciates the continued support of its shareholders and will provide updates as negotiations and expansion initiatives progress.
About Med Holdings Group Inc.
Med Holdings Group Inc. (OTC: YUKA) is a growth-focused healthcare platform pursuing multi-location expansion and scalable digital integration in high-demand wellness and specialty medical markets.
For More Information, Please Contact:
Investor Relations
Email: Info@medholdingsgroup.com
Visit Our Sites:
www.medholdingsgroup.com
www.medsmartcenters.com
Contact Us:
(786) 438-3100
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding the Company's expectations with respect to the role, responsibilities, and anticipated contributions of its Chief Financial Officer; the impact of management changes on the Company's financial reporting, internal controls, strategic planning, and operational execution; and the Company's future operating performance, objectives, and growth strategies. Forward-looking statements are based on management's current expectations and assumptions, including assumptions regarding the Company's business plans, market conditions, regulatory environment, availability of capital, and the Company's ability to execute its strategy and attract and retain qualified personnel. These assumptions may prove to be incorrect, and there can be no assurance that the forward-looking statements will be achieved. Actual results may differ materially from those expressed or implied by forward-looking statements due to risks and uncertainties, including, among others: changes in general economic, financial, regulatory, or competitive conditions; risks associated with management transitions; the Company's ability to implement and maintain effective internal controls and financial reporting processes; the Company's ability to execute its business strategy; and other risks described from time to time in the Company's filings and disclosures. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to place undue reliance on these statements. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances after the date of this press release.
View the original release on www.newmediawire.com
MED Holdings Group IncFAQ**
How does the recent appointment of Dr. Harvey Samowitz impact the strategic direction of Yuka Group Inc. (OTC: YUKA) in the urology and sexual wellness sectors?
What specific metrics or goals has Yuka Group Inc. set to measure the success of its expansion into Jupiter and Doral, Florida?
In what ways does Yuka Group Inc. (YUKA) plan to leverage its digital platform, TotallBody.com, to enhance user engagement and service offerings?
How will the FINRA name and ticker change affect investor perception and market visibility for Yuka Group Inc. (OTC: YUKA)?
**MWN-AI FAQ is based on asking OpenAI questions about Yuka Group Inc (OTC: YUKA).
NASDAQ: YUKA
YUKA Trading
-22.04% G/L:
$0.0467 Last:
20,267 Volume:
$0.0559 Open:
